Martinez-Orozco H, Bencomo-Martinez A, Maya-Arteaga J, Rubio-De Anda P, Sanabria-Romero F, Casas Z
Int J Mol Sci. 2025; 26(3).
PMID: 39941068
PMC: 11818425.
DOI: 10.3390/ijms26031301.
Sabbir M, Swanson M, Albensi B
Front Cell Dev Biol. 2023; 11:1158604.
PMID: 37274741
PMC: 10233041.
DOI: 10.3389/fcell.2023.1158604.
Hajjo R, Sabbah D, Abusara O, Al Bawab A
Diagnostics (Basel). 2022; 12(12).
PMID: 36552984
PMC: 9777434.
DOI: 10.3390/diagnostics12122975.
Yang H, Yang X, Yan S, Sun Z
Sci Rep. 2022; 12(1):14961.
PMID: 36056083
PMC: 9440203.
DOI: 10.1038/s41598-022-19304-3.
Dwomoh L, Tejeda G, Tobin A
Neuronal Signal. 2022; 6(1):NS20210004.
PMID: 35571495
PMC: 9069568.
DOI: 10.1042/NS20210004.
Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders.
Johnson C, Kangas B, Jutkiewicz E, Bergman J, Coop A
Biomedicines. 2022; 10(2).
PMID: 35203607
PMC: 8962391.
DOI: 10.3390/biomedicines10020398.
Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Bungau S
Neurochem Res. 2021; 46(11):2832-2851.
PMID: 34357520
DOI: 10.1007/s11064-021-03415-w.
Dynamics analysis of the hippocampal neuronal model subjected to cholinergic action related with Alzheimer's disease.
Jiang P, Yang X, Sun Z
Cogn Neurodyn. 2020; 14(4):483-500.
PMID: 32655712
PMC: 7334339.
DOI: 10.1007/s11571-020-09586-6.
The Effect of Cumulative Anticholinergic Use on the Cognitive Function of Older Adults: Results from the Personality and Total Health (PATH) Through Life Study.
Neelamegam M, Zgibor J, Chen H, ORourke K, Bakour C, Rajaram L
J Gerontol A Biol Sci Med Sci. 2020; 75(9):1706-1714.
PMID: 32514523
PMC: 7494035.
DOI: 10.1093/gerona/glaa145.
Targeting the Cholinergic System to Develop a Novel Therapy for Huntington's Disease.
DSouza G, Waldvogel H
J Huntingtons Dis. 2016; 5(4):333-342.
PMID: 27983560
PMC: 5181681.
DOI: 10.3233/JHD-160200.
Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations.
Foidl B, Do-Dinh P, Hutter-Schmid B, Bliem H, Humpel C
Neurobiol Learn Mem. 2016; 136:86-96.
PMID: 27670619
PMC: 6020032.
DOI: 10.1016/j.nlm.2016.09.014.
Acetylcholine content and viability of cholinergic neurons are influenced by the activity of protein histidine phosphatase.
Eissing A, Fischer D, Rauch I, Baumann A, Schebb N, Karst U
BMC Neurosci. 2012; 13:31.
PMID: 22436051
PMC: 3355010.
DOI: 10.1186/1471-2202-13-31.
Therapeutic approaches to age-associated neurocognitive disorders.
OHara R, Derouesne C, Fountoulakis K, Yesavage J
Dialogues Clin Neurosci. 2011; 3(3):191-213.
PMID: 22033831
PMC: 3181653.
Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.
Overk C, Felder C, Tu Y, Schober D, Bales K, Wuu J
J Chem Neuroanat. 2010; 40(1):63-70.
PMID: 20347961
PMC: 2864794.
DOI: 10.1016/j.jchemneu.2010.03.005.
MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.
George S, Mufson E, Leurgans S, Shah R, Ferrari C, deToledo-Morrell L
Neurobiol Aging. 2009; 32(10):1756-64.
PMID: 20005600
PMC: 2888825.
DOI: 10.1016/j.neurobiolaging.2009.11.006.
Acetylcholine receptors in dementia and mild cognitive impairment.
Sabri O, Kendziorra K, Wolf H, Gertz H, Brust P
Eur J Nucl Med Mol Imaging. 2008; 35 Suppl 1:S30-45.
PMID: 18228017
DOI: 10.1007/s00259-007-0701-1.
Postoperative pain management and proinflammatory cytokines: animal and human studies.
Shavit Y, Fridel K, Beilin B
J Neuroimmune Pharmacol. 2007; 1(4):443-51.
PMID: 18040817
DOI: 10.1007/s11481-006-9043-1.
The cholinergic hypothesis of Alzheimer's disease: a review of progress.
Francis P, Palmer A, Snape M, Wilcock G
J Neurol Neurosurg Psychiatry. 1999; 66(2):137-47.
PMID: 10071091
PMC: 1736202.
DOI: 10.1136/jnnp.66.2.137.
Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?.
Nilsson L, Adem A, Hardy J, Winblad B, Nordberg A
J Neural Transm. 1987; 70(3-4):357-68.
PMID: 3681290
DOI: 10.1007/BF01253610.
Postmortem- and cryostability of the potassium-evoked release of [3H]5-hydroxytryptamine from rat cerebral cortical miniprisms.
Fowler C, THORELL G, Fagervall I
J Neural Transm. 1989; 75(2):135-48.
PMID: 2918306
DOI: 10.1007/BF01677427.